Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 4, 2025, the Compensation ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

Group received notice from the Listing Qualifications Department of the Nasdaq Stock Market on February 5, indicating that the ...

On February 4, 2025, the Company filed the required Form 6-K to report its unaudited condensed consolidated statements of profit or loss and statements of financial position as of and for the quarter, ...

that it met the minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1). Mainz Biomed had previously met the minimum bid price requirement under Rule 5550(a)(2). With this ...

The Compensation Committee of Chimerix’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing rule 5635(c)(4).

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate ...

Etsy, Inc. (Nasdaq: ETSY), which operates two-sided online marketplaces that connect millions of passionate and creative buyers and sellers around the world, today announced that effective February 3, ...

Webuy Global Ltd. failed to comply with Nasdaq Listing Rule 5550(a)(2), related to maintaining a minimum bid price of $1.00 per share. When will the trading of Webuy Global Ltd.'s shares be suspended?

Singapore, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Webuy Global Ltd. (Nasdaq: WBUY) (the “Company”), today announced that it received a letter on January 22, 2025, from the Listing Qualifications ...

The Company is preparing for an annual meeting for its shareholders, demonstrating an active effort to regain compliance with Nasdaq listing rules. Fenbo expects to regain compliance with the ...